Find out about cannabis-based products, when are they used and the possible side effects. Cannabidiol (CBD) is a substance found in cannabis that has potential therapeutic value and little-to-no psychoactive properties. CBD products are prescription-only medicines. This page contains information on medicinal cannabis products that meet the medicinal cannabis minimum quality standard.
Commonly asked questions about cannabis-based products
The term cannabis-based products covers several types of products that may be prescribed to treat various medical conditions.
On this page, you can find the following information:
What are cannabis-based products?
Cannabis-based product is the preferred term for any product containing cannabis or a cannabinoid. Cannabinoids are chemical compounds found in the plant Cannabis sativa, also known as marijuana. They can also be human-made (synthetic). There are more than 100 identified cannabinoids. Cannabidiol (CBD) and tetrahydrocannabinol (THC) are the most studied of the cannabinoids and the most commonly included ingredients in cannabis-based products. They may be present as individual ingredients or together in a combination.
- This is a non-psychoactive cannabinoid, which means that it does not affect your mind or mental processes and does not give you a ‘high’ like THC does.
- This is a psychoactive cannabinoid.
- THC binds to cannabinoid receptors in your brain and causes most of the psychological effects such as elated mood (feeling ‘high’), fast heart rate, dizziness and slow reaction times.
- Potency or strength depends on a number of factors such as the plant age, plant genetics, harvesting and processing.
What is medicinal cannabis and is it different to recreational cannabis?
Medicinal cannabis is used for medicinal purposes to relieve the symptoms of a medical condition. It can be a dried cannabis product or a product in a pharmaceutical dosage form (eg, tablets or capsules) containing 1 or more cannabis-based ingredients and no other prescription medicines or controlled drugs. You must have a prescription from a prescriber registered to practice in Aotearoa New Zealand before you can be supplied any medicinal cannabis product.
Recreational cannabis is the use of cannabis for the purpose of getting ‘high’ without any medical reason for using it.
In what forms is medicinal cannabis available?
Medicinal cannabis is usually available as:
- oral drops, lozenges or capsules
- a mouth spray
- a form that can be inhaled via a medical vapouriser device (non-combustion)
- gel or patches that are applied to your skin.
A product does not classify as a medicinal cannabis product if it is in a form intended for smoking, a food or a sterile dosage form (eg, eye drops).
Do medicinal cannabis products in Aotearoa New Zealand meet a quality standard?
On 1 April 2020, the Ministry of Health’s Medicinal Cannabis Agency began accepting applications from medicinal cannabis product suppliers to assess their products. The purpose of an assessment is to establish whether the product meets the medicinal cannabis minimum quality standard and to improve access to quality products. The minimum quality standards provide prescribers with confidence in the quality and consistency of any medicinal cannabis products they prescribe to their patients.
For a list of medicinal cannabis products that meet the minimum quality standard, see medicinal cannabis products that meet the minimum quality standard. A range of further medicinal cannabis products will become available over time as suppliers of medicinal cannabis products apply to the Medicinal Cannabis Agency to assess whether their products meet the medicinal cannabis minimum quality standard.
The Medicinal Cannabis Agency does not currently assess products for their safety or efficacy.
Do I need a prescription for medicinal cannabis?
Yes, you need a prescription from any registered prescriber (such as a doctor or nurse practitioner) in Aotearoa New Zealand before you can get any medicinal cannabis product. The prescriber will need to check if the product meets the quality standard by the Medicinal Cannabis Agency. They will ask you about your medical history, including any other medicines you are taking. Your prescriber is best placed to advise you on the risks and benefits of using medicinal cannabis products.
With a prescription, your prescriber or a pharmacy will dispense the product. You cannot buy medicinal cannabis products online or from a third party.
Can I import medicinal cannabis products from overseas?
No, personal imports of medicinal cannabis products are not allowed. You can only get medicinal cannabis products from a registered medical practitioner in Aotearoa or a pharmacy that is importing the medicinal cannabis products on behalf of the medical practitioner.
The current policy on importing cannabis based products is that any medicinal cannabis product is considered to have a therapeutic purpose and will be treated as a prescription medicine when imported. This means that you cannot import medicinal cannabis products for personal use, including in the form of cosmetics, beauty products, jewellery or any other products that contain cannabis.
Do cannabis-based medicinal products work?
The scientific evidence for the effectiveness and safe use of cannabis-based products is not considered strong. In general there is not yet enough information to fully recommend their use. One of the main issues is that there are limited pharmaceutical grade cannabis-based products available for use and there is a lot of variation in the quality of products used. Trialling a cannabis-based product is only a suitable option for people who have ongoing symptoms after trying available conventional treatments. Medicinal cannabis is not considered a first option for any medical condition.
Certain cannabis-based products may provide some moderate improvements in symptoms for people with:
- Multiple sclerosis-associated spasticity.
- Seizures associated with refractory epilepsy such as Dravet syndrome or Lennox-Gastaut syndrome.
- Chronic pain, specifically nerve pain.
- Nausea (feeling sick) and vomiting (being sick) caused by cancer therapy.
There is a lack of evidence to support the use of cannabis-based products for depressive disorders, post-traumatic stress disorder (PTSD), Parkinson’s disease, anxiety, obsessive-compulsive disorder (OCD), autism, ulcerative colitis, Alzheimer’s disease, glaucoma and Crohn’s disease.
What is the dose of medicinal cannabis?
The recommended dose is difficult to determine due to individual differences in people’s response and the products used. Some people are very sensitive to it whereas others need to use more to produce an effect. Other reasons that make dosing difficult to determine include the following:
- Products are not equivalent and have different ratios of CBD and THC, which can affect your body in different ways when used in a combination. This means that finding the right dose needs trying first and then adjusting.
- Individual differences exist and some find that their dosage needs to change when the product brand is changed.
- Cannabis-based products intended for inhalation are harder to dose. Flower-based products require the use of a medical vapouriser, which helps control the dose received by adjusting the temperature and amount of product used. However, this is not an exact science and it makes dosing harder to determine.
It is best to start a cannabis-based product at a low dose and gradually increase it to reduce the chance of side effects. Your doctor will also provide you with guidance on adjusting your dose.
What are the side effects of cannabis-based products?
Cannabis-based products can cause side effects and these differ between people and products. No studies have not been done to assess the long-term adverse effects of cannabis-based products. Common mild side effects include:
- nausea (feeling sick)
- indigestion, stomach upset
- stomach pain or cramps
- diarrhoea (runny poo)
- dry mouth.
Did you know that you can report a side effect to a medicine to CARM (Centre for Adverse Reactions Monitoring)? Report a side effect to a product.
Who should not use cannabis-based products?
Cannabis based products may not be appropriate for some people. These include people who:
- have a personal or strong family history of psychosis
- have an active mood disorder
- are pregnant and breastfeeding
- have heart rhythm problems
- have had recent heart attacks or strokes
- have severe liver or kidney problems.
Can I take cannabis-based products with medicines?
Cannabis-based products have several interactions with medicines, herbal products and illicit or recreational products. This is mostly because of the way they are broken down (metabolised) in your body. Some combinations can have serious effects. Your prescriber or pharmacist will be able to check for interactions. If you are taking medicinal cannabis, it is really important to tell your healthcare provider before starting any medicine or herbal product.
What do I need to know before travelling with medicinal cannabis?
Entering Aotearoa New Zealand
If you are travelling, you may bring a medicinal cannabis product into Aotearoa New Zealand if:
- the product has been prescribed to you by a registered prescriber
- you have a copy of the prescription or a letter from your prescriber stating that you are being treated with the product
- you declare the product on your passenger arrival card
- you carry the product in its original container, and
- you are bringing no more than a 3 month supply of a CBD product or a 1 month supply of any other medicinal-cannabis product.
Taking medicinal cannabis products overseas
Before you travel overseas, make sure you check how medicinal cannabis products are classified in any places you plan to visit or transit through. In some countries, possession of cannabis is a criminal offence, with no exemption for medicinal cannabis products.
Other terms you may come across
- Cannabinoids: These are the chemical compounds found in the plant Cannabis sativa. There are more than 100 identified cannabinoids. THC and CBD are the most recognised and studied among these.
- Cannabis: This term refers to the cannabis plants Cannabis sativa cultivated as the source of THC. Cannabis has a THC content of more than 0.35%.
- Cannabis-based product: This is the preferred term for any product containing cannabinoid. This includes products derived from natural or synthetic components of the Cannabis sativa plant.
- Hashish/hash: This refers to the resin derived from the cannabis plant that has a psychoactive effect.
- Hemp: Cannabis that contains very low amounts of THC in its flowers and leaves (less than 0.35%) is classified as hemp.
- Marijuana: This is an alternative name for cannabis when it is used as a psychoactive substance. It usually refers to the dried, crushed flowers and leaves.
- Medicinal cannabis: This refers to the use of all forms of cannabis-based products for medical purposes, that is, to treat a medical condition or symptoms. ‘Medicinal cannabis’ is not a preferred term as the majority of products do not meet the criteria associated with a medicine.
- Hemp seed: These are the seeds of the Cannabis sativa plant. The seeds do not contain THC or CBD. Other parts of the plant (eg, leaves and flowers) contain THC and CBD that could contaminate the seed if not processed correctly.
- Hemp seed oil (also known as hemp oil): This is obtained by pressing hemp seeds. Classified as a food, it does not contain THC or CBD. It is not to be confused with CBD oil.
- Synthetic CBD products: These are CBD products that have been synthetically manufactured rather than coming from the cannabis plant. Currently, no non-cannabis-derived CBD products have been approved by Medsafe.
BPAC, NZ, 2022 Therapeutic Goods Administration, Department of Health, Australia Australian and New Zealand College of Anaesthetists & Faculty of Pain Medicine, 2022 BPAC, NZ Ministry of Health, NZ
Additional resources for healthcare professionals
Te reo resources
The Māori Pharmacists’ Association Ngā Kaitiaki o Te Puna Rongoā has a free phone line to answer questions whānau have about their medicines. Call 0800 664 688.
Note: This is a non-urgent service and they will get back to you within 24 hours.
For urgent health advice freephone Healthline 0800 611 116.
Pain relief medications
Non-medicine treatments for pain
Multiple sclerosis | Wharanga uwhi iaia
Credits: Health Navigator Pharmacists. Reviewed By: Maya Patel, MPharm PGDipClinPharm, Auckland Last reviewed: 03 Apr 2022 Page last updated: 08 Jun 2022
“ I am a practice nurse and it’s important that I can direct my patients to good, reliable sources, so they can educate themselves and therefore improve health outcomes for them and their families/whānau, as well as helping to slow/reduce the risks for us all. ”
2022 Survey feedback 5
“ 10 / 10 Love the simple language that you use, but also the strong evidence-based nature of the info you provide. This website is always my go to for trusted information for my patients. ”
2022 Survey feedback 2
“ Thanks for the great service. I love that it’s free and doesn’t have heaps of ads popping up everywhere. Overall, a pleasure to use thank you. ”
2022 Survey feedback 3
“ Health Navigator provides the whole package of information on a topic. There is a high level of health literacy for the website itself and the information provided. ”
Quality Improvement Manager, Marlborough PHO
“ Health Navigator is such a valuable resource. It’s useful for consumers, health professionals and health students as it covers a diverse range of topics, the explanations are easy to understand, and most importantly is credible and NZ focussed. ”
Dr Michelle Honey
Nursing Senior Lecturer, Auckland
“ I always recommend Health Navigator resources to my patients. It provides high quality, reliable, NZ relevant information in a clearly organized and easy to understand way. This means people can quickly get the key information or dig deeper when needed. ”
Dr Rebecca Grainger
Rheumatologist & researcher, University of Otago, Wellington
“ I use Health Navigator because my doctor recommended it as the go-to site where the information can be trusted. And because my experience here has supported this. ”
2022 Survey feedback 4
Website survey, 2016
“ I don’t have time to assess the quality of the many websites out there I would want to refer people to. Health Navigator solves this in one easy step. It is my “go to place” to send people for great information and self-management support. ”
Dr David Codyre
Primary care psychiatrist
“ I often refer colleagues, patients and friends to Health Navigator. It is a trusted site with clearly written health information for New Zealanders. It is wonderful to have a good collection of translated resources too. ”
“ I was really impressed because health is covered in its entirety. It’s a very useful site for clinicians or anyone interested in gaining knowledge around the current status of indigenous wellbeing here in Aotearoa. ”
Mary Maringikura Campbell (Consumer Consultant)
“ Health Navigator offers people different ways to learn about their health. It’s New Zealand-based and developed by New Zealanders so the information is relevant to us. ”
Dr. Jeff Lowe
GP Karori Medical Centre & Chair GPNZ
“ 10 / 10. User friendly website, language is easy to follow. This enables [my] whānau to manage health related issues as best they can. ”
2022 Survey feedback 1
“ Health Navigator is an excellent ‘go-to’ site for New Zealanders. The articles are well written and very clear to understand. They provide enough information to make an informed choice as to where to go next. An excellent resource. ”
Medical Library Manager
“ 10 / 10 It’s informative and interesting, and it’s great to see real people sharing real stories and real innovations that work! I love the Māori and Pasifika world views. ”
2022 Survey feedback 6
“ Our nurses, doctors, pharmacists and other professionals find Health Navigator a trustworthy, understandable and up -to -date source of health information that we and our patients and their whanau can access at a time and pace appropriate to them. ”
Medicinal Cannabis Agency – Cannabidiol (CBD) products
Cannabidiol (CBD) is a substance found in cannabis that has potential therapeutic value and little-to-no psychoactive properties. CBD products are prescription-only medicines.
Definition of a CBD product
To be considered a ‘CBD product’ under Section 2A of the Misuse of Drugs Act 1975, the tetrahydrocannabinols (THCs) and specified substances within the product must not exceed 2 percent of the total CBD, tetrahydrocannabinol (THC) and other specified substances.
A Certificate of Analysis from the supplier is required to determine the quantities of CBD and specified substances. If a product contains CBD but does not meet the definition of a CBD product, it is a ‘controlled drug’ and is subject to the regulatory requirements of the Misuse of Drugs Act.
The following examples may assist to determine whether your product meets the definition of a CBD product:
|Category of product||Total amount of CBD||Total amount of THC and specified substances||Percent specified substances|
|CBD product||49 mg||0.7 mg||(0.7) ÷ (49+0.7) x 100 = 1.4%|
|Non-CBD product||5 mg||0.7 mg||(0.7) ÷ (5+0.7) x 100 = 12.3%|
Under Section 2A of the Misuse of Drugs Act 1975, a specified substance is a substance that:
- naturally occurs in cannabis; and
- is —
- a tetrahydrocannabinol; or
- an isomer, ester, or ether of a tetrahydrocannabinol; or
- an ester or ether of an isomer of a tetrahydrocannabinol; or
- a salt of any substance described in (i) to (iii); or
- a substance that has a structure substantially similar to that of any substance described in (i) to (iv); and
The definition of “by any means” includes simple conversion techniques such as heating.
Requirements for a Certificate of Analysis
A Certificate of Analysis can be obtained from the distributor or manufacturer of the CBD product. At a minimum, it should state the:
- details of the laboratory which conducted the analysis
- the laboratory’s ISO accreditation to ISO/IEC 17025:2017
- the date the analysis was carried out
- the name of the product and batch number of the batch analysed
- the amount of CBD, CBDA, Δ9-THC, Δ9-THCA and CBN
- the amount of any other specified substance that is present at detectable levels
- the limits of detection or quantification for all tested substances.
Importing CBD products
If you intend to import and supply CBD products you will need to hold a licence issued under the Medicines Act 1981. This licence must expressly authorise the specific CBD product being imported or supplied. A medicinal cannabis licence is not required.
Before you import a specific CBD product for supply for the first time, you will need to apply to the Medicinal Cannabis Agency for a product assessment to verify it meets the definition of a CBD product and meets the medicinal cannabis minimum quality standard.
You will also need to provide information to establish that the product being imported is the same as the product specified on the Medicines Act licence.
A Certificate of Analysis will typically be sufficient to determine the quantities of CBD and any specified substances, and to establish whether the definition has been met.
A CBD product that has not been verified to have met the minimum quality standard can be imported only by a medical practitioner or pharmacist for a named patient.
Note that many products currently listed on websites as CBD products do not meet the New Zealand definition of a CBD product because the THC content is too high. Therefore, these products are classified as controlled drugs and are treated the same as other medicinal cannabis products.
For further information, please refer to the Ministry of Health guidance on bringing medicines into New Zealand. Further information is also available on the Medsafe webpage.
Personal imports of CBD products
Personal imports of CBD products are not permitted.
A person wishing to import a CBD product for personal use is unlikely to have the information needed to establish that the product meets the minimum quality standard.
If importation of an unverified CBD product is being considered, it should be imported by the prescriber or pharmacy on behalf of the patient.
Domestic manufacture for supply or export
Finished products that meet the definition of a CBD product are not ‘controlled drugs’ under the Misuse of Drugs Act 1975. However, you do need to hold a medicinal cannabis licence with a ‘Possession for manufacture’ activity for the manufacture of a CBD product from cannabis or any cannabis-based ingredient other than pure CBD extract.
Your medicinal cannabis licence does not need to have a ‘Supply’ activity specified in order to supply or export CBD products.
In addition to a medicinal cannabis licence with a ‘Possession for manufacture’ activity to manufacture CBD products, you will need a Licence to Manufacture Medicines issued under the Medicines Act 1981 that expressly authorises the manufacture of a CBD product. This will allow you to manufacture, test, pack and label the CBD product or dosage form.
Before you can supply a CBD product you will need to apply to the Medicinal Cannabis Agency for a product assessment to establish it meets the minimum quality standard.
If your planned activities are limited to re-packing CBD products that have been manufactured by a GMP-compliant facility and verified to meet the minimum quality standard, a Licence to Pack Medicines is required instead of a Licence to Manufacture Medicines. This will allow you to pack and label the CBD product only.
To obtain either licence, you will need to demonstrate compliance with the New Zealand Code of Good Manufacturing Practice for Manufacture and Distribution of Therapeutic Goods (the Code of GMP).
Non-cannabis derived CBD products
Synthetic CBD products are unable to be verified to meet the minimum quality standard as they are not derived from the Cannabis plant.
This means that CBD products that have been synthetically manufactured or isolated other than from cannabis (ie, non-cannabis -derived CBD products):
Medicinal cannabis products that meet the minimum quality standard
13 September 2022: New medicinal cannabis products have been verified as meeting the minimum quality standard – Read more.
Generally, medicinal cannabis products are only available, on prescription, if they have:
- been assessed by the Medicinal Cannabis Agency as meeting the minimum quality standard under the Misuse of Drugs (Medicinal Cannabis) Regulations 2019, or
- obtained consent for distribution under the Medicines Act 1981 (approved and provisionally approved medicines)
Any doctor can prescribe a product listed here. A specialist recommendation and Ministerial approval are not required. For more information on a particular product, please contact the listed product supplier or manufacturer.
Medicinal cannabis products that meet the minimum quality standard under the Misuse of Drugs (Medicinal Cannabis) Regulations 2019
The minimum quality standard is used to verify medicinal cannabis products which have been derived from the Cannabis plant. Synthetic CBD and THC products are unable to be verified to meet the minimum quality standard as they are not derived from the Cannabis plant.
Products that are listed as having been verified as meeting the minimum quality standards are unapproved medicines – there has been no assessment of their safety or efficacy. Being listed here does not guarantee that these products are currently available in New Zealand. Contact the licence holder to obtain the most up-to-date information on product availability.
Dosage Products – Prescription Medicine
The products listed in the following tables are categorised by their verified dosage form. The products have been verified as meeting the testing requirements and microbiological contamination limits applicable to the dosage form as listed.